Small-cell carcinoma of the lung: Derivation of a prognostic staging system

Journal of Clinical Oncology

Volumn 9, Issue 9, 1991, Pages 1639-1649

  Sagman, U ^b   Maki, E ^b   Evans, W K ^b   Warr, D ^b   Shepherd, F A ^b   Sculier, J P ^b   Haddad, R ^b   Payne, D ^b   Pringle, J F ^b   Yeoh, J L ^b   Ciampi, A ^b   DeBoer, G ^b   McKinney, S ^b   Ginsberg, R ^b   Feld, R ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALKALINE PHOSPHATASE; ANTINEOPLASTIC AGENT; CARCINOEMBRYONIC ANTIGEN; CYCLOPHOSPHAMIDE; DOXORUBICIN; ETOPOSIDE; FOLINIC ACID; LACTATE DEHYDROGENASE; LOMUSTINE; METHOTREXATE; PROCARBAZINE; VINCRISTINE;

ADULT; AGED; CONFERENCE PAPER; FEMALE; HUMAN; LEUKOCYTE COUNT; LUNG SMALL CELL CANCER; MAJOR CLINICAL STUDY; MALE; METASTASIS; PRIORITY JOURNAL; PROGNOSIS; THROMBOCYTE COUNT;

ADULT; AGED; AGED, 80 AND OVER; ANALYSIS OF VARIANCE; CARCINOMA, SMALL CELL; FEMALE; HUMAN; LUNG NEOPLASMS; MALE; MIDDLE AGE; NEOPLASM STAGING; PROGNOSIS; REGRESSION ANALYSIS; RETROSPECTIVE STUDIES; SURVIVAL RATE;

EID: 0025785289     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.1991.9.9.1639     Document Type: Article

References (37)

1. Silverberg E, Boring CC, Squires TS: Cancer statistics, 1990. Ca 40:9-28, 1990
2. Minna JD, Higgins GA, Glatstein EJ: Cancer of the lung, in DeVita VT, Hellman S, Rosenberg SA (eds): Cancer, Principles and Practice of Oncology, 3rd ed. Philadelphia, PA, Lippincott, 1989, pp 591-705
3. Morstyn G, Ihde DC, Lichter AS, et al: Small cell lung cancer 1973-1983: Early progress and recent obstacles. Int J Radiat Oncol Biol Phys 10:515-539, 1984
4. Miller AB, Fox W, Tall R: Five-year follow-up of the Medical Research Council comparative trial of surgery and radiotherapy for the primary treatment of small or oat-cell carcinoma of the bronchus. Lancet 2:501-505, 1969
5. Bergsagel DE, Jenkin RDT, Pringle JF, et al: Lung cancer: Clinical trial of radiotherapy alone versus radiotherapy plus cyclophosphamide. Cancer 30:621-627, 1972
6. Evans WK, Shepherd FA, Feld R, et al: VP-16 and cisplatin as first-line therapy for small cell lung cancer. J Clin Oncol 3:1471-1477; 1985
7. Maurer LH, Pajak TF: Prognostic factors in small cell carcinoma of the lung: A Cancer and Leukemia Group B study. Cancer Treat Rep 65:767-774, 1981
8. Osterlind K, Ihde DC, Ettinger DS, et al: Staging and prognostic factors in small cell carcinoma of the lung. Cancer Treat Rep 67:3-8, 1983
9. Cohen MH, Makuch R, Johnston-Early A, et al: Laboratory parameters as an alternative to performance status in prognostic stratification of patients with small-cell lung cancer. Cancer Treat Rep 65:187-195, 1981
10. Stanley KE: Prognostic factors in lung cancer, in Aisner J (ed): Lung Cancer. New York, NY, Churchill Livingstone, 1985, pp 41-66
11. Souhami RL, Bradbury J, Geddes DM, et al: Prognostic significance of laboratory parameters measured at prognosis in small cell carcinoma of the lung. Cancer Res 45:2878-2882, 1985
12. Osterlind K, Anderson PK: Prognostic factors in small cell lung cancer: Multivariate model based on 728 patients with chemotherapy with or without irradiation. Cancer Res 46:4189-4194, 1986
13. Vincent MD, Ashley SE, Smith IE: Prognostic factors in small cell lung cancer: A simple prognostic index is better than conventional staging. Eur J Cancer Clin Oncol 23:1589-1599, 1987
14. Spiegelman D, Maurer H, Ware JH, et al: Prognostic factors in small cell carcinoma of the lung: An analysis of 1521 patients. J Clin Oncol 7:344-354, 1989
15. The World Health Organization: Histological Typing of Lung Tumors, ed 2. Geneva, Switzerland, WHO, 1981
16. Feld R, Pringle JF, Evans WK, et al: Combined modality treatment of small cell carcinoma of the lung. Arch Intern Med 141:469-473, 1981
17. Feld R, Evans WK, DeBoer G, et al: Combined modality induction therapy without maintenance chemotherapy for small cell carcinoma of the lung. J Clin Oncol 2:294-301, 1984
18. Feld R, Evans WK, Coy P, et al: Canadian multicenter randomized trial comparing sequential and alternating administration of two non-cross resistant chemotherapy combinations in patients with limited small cell carcinoma of the lung. J Clin Oncol 5:1401-1409, 1987
19. Evans WK, Feld R, Murray N, et al: Superiority of alternating non-cross resistant chemotherapy in extensive small cell lung cancer: The results of a multicentre randomized National Cancer Institute of Canada clinical trial. Ann Intern Med 107:451-458, 1987
20. Clamon GH, Feld R, Evans WK, et al: The effect of adjuvant central I.V. hyperalimentation on the survival and response to treatment of patients with small cell lung cancer. A randomized trial. Cancer Treat Rep 69:167-168, 1985
21. Zubrod CG, Schneiderman, Frei E, et al: Appraisal of methods for the study of chemotherapy for cancer in man: Comparative therapeutic trial of nitrogen mustard and triethylene thiophosphoramide. J Chron Dis 11:7-33, 1960
22. Shepherd FA, Ginsberg R, Haddad R, et al: "Very limited" small cell lung cancer (SCLC)-Results of nonsurgical treatment. Proc Am Soc Clin Oncol 3:223, 1984 (abstr 870)
23. Kaplan EI, Meier P: Nonparametric estimation from incomplete observations. J Am Stat Assoc 53:457-481, 1958
24. Cox DR: Regression models and life tables. J R Stat Soc B 34:187-202, 1972
25. Kalbfleisch JD, Prentice RL: The Statistical Analysis of Failure Time Data. New York, NY, Wiley, 1980
26. BMDP Statistical Software. Berkeley, CA, University of California Press, 1981
27. SAS Institute Inc: SAS User's Guide: Statistics, Version 5 Edition. Cary, NC, SAS Institute Inc, 1985
28. Gail MH, Muenz L, McIntire KR, et al: Multiple markers for lung cancer diagnosis: Validation of models for advances in lung cancer. J Natl Cancer Inst 76:805-816, 1986
29. Goldman L, Cook EF, Brand DA, et al: A computer protocol to predict myocardial infarction in emergency department patients with chest pain. N Engl J Med 318:797-803, 1988
30. Ciampi A, Thiffault J, Sagman U: RECPAM: A computer program for recursive partition and amalgamation for censored survival data and other situations frequently occurring in biostatistics. II. Applications to data on small cell lung (SCCL). Comput Methods Programs Biomed 30:283-296, 1989
31. Marubini E, Morabito A, Valsecchi MG: Prognostic factors and risk groups: Some results given by using an algorithm suitable for censored survival data. Stat Med 2:295-303, 1983
32. Ciampi A, Chi-Hsing C, Hogg SA, et al: Recursive partition: A versatile method for exploratory data analysis in biostatistics, in Umphreys G (ed): Proc form Joshi Festschrift. Amsterdam, North Holland, 1986
33. Agresti A: Analysis of Ordinal Categorical Data. New York, NY, Wiley, 1984
34. Zelen M: Keynote address on biostatistics and data retrieval. Cancer Chemother Rep 4:31-37, 1973
35. Østerlind K, Hansen HH, Hansen M, et al: Long-term disease-free survival in small-cell carcinoma of the lung: A study of clinical determinants. J Clin Oncol 4:1307-1313, 1986
36. Sculier JP, Feld R, Evans WK, et al: Carcinoembryonic antigen: A useful prognostic marker in small-cell lung cancer. J Clin Oncol 3:1349-1354, 1985
37. Albain KS, Crowley JJ, LeBlanc M, et al: Determinants of improved outcome in small-cell lung cancer: An analysis of the 2,580-patient South West Oncology Group data base. J Clin Oncol 8:563-574, 1990